TrialThe oncologist2017

The European Medicines Agency Review of Carfilzomib for the Treatment of Adult Patients with Multiple Myeloma Who Have Received at Least One Prior Therapy.

Kyriaki Tzogani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.